Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 726

1.

Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors.

Okamoto S, Suzuki N, Suzuki A, Suzuki S, Tamura S, Suzuki M, Takahashi N, Kojima T, Kanematsu T, Kojima T, Kiyoi H, Ishiguro N, Matsushita T.

TH Open. 2019 Dec 5;3(4):e364-e366. doi: 10.1055/s-0039-3401001. eCollection 2019 Oct.

2.

Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.

Yamawaki Y, Shirawachi S, Mizokami A, Nozaki K, Ito H, Asano S, Oue K, Aizawa H, Yamawaki S, Hirata M, Kanematsu T.

Neurochem Int. 2019 Dec;131:104563. doi: 10.1016/j.neuint.2019.104563. Epub 2019 Oct 4.

3.

Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.

Yoshimura A, Yamada T, Okuma Y, Kitadai R, Takeda T, Kanematsu T, Goto H, Yoneda H, Harada T, Kubota Y, Yamada T, Date K, Shiotsu S, Nagata K, Chihara Y, Kaneko Y, Uchino J, Nishioka Y, Takayama K.

Transl Lung Cancer Res. 2019 Aug;8(4):450-460. doi: 10.21037/tlcr.2019.08.07.

4.

Phospholipase C-related catalytically inactive protein regulates cytokinesis by protecting phosphatidylinositol 4,5-bisphosphate from metabolism in the cleavage furrow.

Asano S, Ikura Y, Nishimoto M, Yamawaki Y, Hamao K, Kamijo K, Hirata M, Kanematsu T.

Sci Rep. 2019 Sep 4;9(1):12729. doi: 10.1038/s41598-019-49156-3.

5.

Phospholipase C-related inactive protein type-1 deficiency affects anesthetic electroencephalogram activity induced by propofol and etomidate in mice.

Furukawa T, Nikaido Y, Shimoyama S, Ogata Y, Kushikata T, Hirota K, Kanematsu T, Hirata M, Ueno S.

J Anesth. 2019 Aug;33(4):531-542. doi: 10.1007/s00540-019-02663-z. Epub 2019 Jul 22.

PMID:
31332527
6.

Ccr7 null mice are protected against diet-induced obesity via Ucp1 upregulation and enhanced energy expenditure.

Sano T, Sanada T, Sotomaru Y, Shinjo T, Iwashita M, Yamashita A, Fukuda T, Sanui T, Asano T, Kanematsu T, Nishimura F.

Nutr Metab (Lond). 2019 Jul 4;16:43. doi: 10.1186/s12986-019-0372-5. eCollection 2019.

7.

Performance evaluation of Revohem FVIII chromogenic and Revohem FIX chromogenic in the CS-5100 autoanalyser.

Suzuki A, Suzuki N, Kanematsu T, Shinohara S, Arai N, Kikuchi R, Matsushita T.

Int J Lab Hematol. 2019 Oct;41(5):664-670. doi: 10.1111/ijlh.13083. Epub 2019 Jul 4.

PMID:
31271527
8.

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jul;110(1):125-126. doi: 10.1007/s12185-019-02663-5.

PMID:
31119612
9.

Phospholipase C-related catalytically inactive protein: A novel signaling molecule for modulating fat metabolism and energy expenditure.

Kanematsu T, Oue K, Okumura T, Harada K, Yamawaki Y, Asano S, Mizokami A, Irifune M, Hirata M.

J Oral Biosci. 2019 Jun;61(2):65-72. doi: 10.1016/j.job.2019.04.002. Epub 2019 May 15. Review.

PMID:
31109860
10.

Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.

Odaira K, Tamura S, Suzuki N, Kakihara M, Hattori Y, Tokoro M, Suzuki S, Takagi A, Katsumi A, Hayakawa F, Okamoto S, Suzuki A, Kanematsu T, Matsushita T, Kojima T.

Thromb Res. 2019 Jul;179:95-103. doi: 10.1016/j.thromres.2019.04.022. Epub 2019 May 1.

PMID:
31102861
11.

Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.

Nagao A, Suzuki N, Takedani H, Yamasaki N, Chikasawa Y, Sawada A, Kanematsu T, Nojima M, Higasa S, Amano K, Fukutake K, Fujii T, Matsushita T, Suzuki T.

Haemophilia. 2019 Jul;25(4):e223-e230. doi: 10.1111/hae.13749. Epub 2019 May 2.

PMID:
31045306
12.

Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.

Takayama T, Aramaki O, Shibata T, Oka M, Itamoto T, Shimada M, Isaji S, Kanematsu T, Kubo S, Kusunoki M, Mochizuki H, Sumiyama Y.

Surg Today. 2019 Oct;49(10):859-869. doi: 10.1007/s00595-019-01813-w. Epub 2019 Apr 27.

PMID:
31030266
13.

Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.

Tamura S, Hashimoto E, Suzuki N, Kakihara M, Odaira K, Hattori Y, Tokoro M, Suzuki S, Takagi A, Katsumi A, Hayakawa F, Suzuki A, Okamoto S, Kanematsu T, Matsushita T, Kojima T.

Thromb Res. 2019 Jun;178:159-170. doi: 10.1016/j.thromres.2019.04.004. Epub 2019 Apr 11.

PMID:
31030036
14.

Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16.

Nakatsu Y, Matsunaga Y, Yamamotoya T, Ueda K, Inoue MK, Mizuno Y, Nakanishi M, Sano T, Yamawaki Y, Kushiyama A, Sakoda H, Fujishiro M, Ryo A, Ono H, Minamino T, Takahashi SI, Ohno H, Yoneda M, Takahashi K, Ishihara H, Katagiri H, Nishimura F, Kanematsu T, Yamada T, Asano T.

Cell Rep. 2019 Mar 19;26(12):3221-3230.e3. doi: 10.1016/j.celrep.2019.02.066.

15.

Daikenchuto accelerates the recovery from prolonged postoperative ileus after open abdominal surgery: a subgroup analysis of three randomized controlled trials.

Kono T, Shimada M, Nishi M, Morine Y, Yoshikawa K, Katsuno H, Maeda K, Koeda K, Morita S, Watanabe M, Kusano M, Sakamoto J, Saji S, Sokuoka H, Sato Y, Maehara Y, Kanematsu T, Kitajima M.

Surg Today. 2019 Aug;49(8):704-711. doi: 10.1007/s00595-019-01787-9. Epub 2019 Feb 25.

16.

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Apr;109(4):409-417. doi: 10.1007/s12185-019-02607-z. Epub 2019 Jan 31. Erratum in: Int J Hematol. 2019 Jul;110(1):125-126.

PMID:
30701467
17.

Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.

Suzuki A, Suzuki N, Kanematsu T, Shinohara S, Arai N, Kikuchi R, Matsushita T.

Thromb Res. 2019 Feb;174:98-103. doi: 10.1016/j.thromres.2018.12.018. Epub 2018 Dec 18.

PMID:
30584960
18.

A rare case of gradual enlargement of a multifocal myelolipoma of the posterior mediastinum for 12 years after surgical resection of an adrenal myelolipoma.

Haro A, Fujishita T, Nishikawa H, Taguchi Y, Kouda T, Kajiwara K, Makino H, Kanematsu T, Oshiro Y, Yokoyama H.

Int J Surg Case Rep. 2018;51:400-403. doi: 10.1016/j.ijscr.2018.09.027. Epub 2018 Sep 23.

19.

Development of Drug-in-Adhesive Patch with a Honeycomb Film as a Backing Layer.

Suzuki T, Sakisako Y, Kurihara Y, Aoki T, Kanematsu T, Todo H, Sugibayashi K.

Chem Pharm Bull (Tokyo). 2018;66(9):851-858. doi: 10.1248/cpb.c18-00311.

20.

[The consciousness survey and the effect of educational intervention of Advance Care Planning (ACP) including post-mortem to elderly residents living in old New Town of big city].

Akatsu H, Manabe T, Takeo J, Kawade Y, Kimura Y, Kondo M, Ito S, Nagano K, Nozaki Y, Dhoi M, Masaki Y, Tanaka H, Kanematsu T, Kojima M, Akashi K, Iwata A, Suzuki T, Kimura K, Asai K, Ohara H.

Nihon Ronen Igakkai Zasshi. 2018;55(3):358-366. doi: 10.3143/geriatrics.55.358. Japanese.

21.

Vwf K1362A resulted in failure of protein synthesis in mice.

Sanda N, Suzuki N, Suzuki A, Kanematsu T, Kishimoto M, Hasuwa H, Takagi A, Kojima T, Matsushita T, Nakamura S.

Int J Hematol. 2018 Apr;107(4):428-435. doi: 10.1007/s12185-017-2394-y. Epub 2018 Feb 1.

PMID:
29392565
22.

Poor Motor-Function Recovery after Spinal Cord Injury in Anxiety-Model Mice with Phospholipase C-Related Catalytically Inactive Protein Type 1 Knockout.

Fujita T, Kumagai G, Liu X, Wada K, Tanaka T, Kudo H, Asari T, Fukutoku T, Sasaki A, Nitobe Y, Nikaido Y, Furukawa KI, Hirata M, Kanematsu T, Ueno S, Ishibashi Y.

J Neurotrauma. 2018 Jun 15;35(12):1379-1386. doi: 10.1089/neu.2017.5492. Epub 2018 Mar 13.

PMID:
29336201
23.

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

Goto H, Okano Y, Machida H, Hatakeyama N, Ogushi F, Haku T, Kanematsu T, Urata T, Kakiuchi S, Hanibuchi M, Sone S, Nishioka Y.

Respir Investig. 2018 Jan;56(1):80-86. doi: 10.1016/j.resinv.2017.09.003. Epub 2017 Oct 21.

PMID:
29325686
24.

Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice.

Yamawaki Y, Yoshioka N, Nozaki K, Ito H, Oda K, Harada K, Shirawachi S, Asano S, Aizawa H, Yamawaki S, Kanematsu T, Akagi H.

Brain Res. 2018 Feb 1;1680:13-38. doi: 10.1016/j.brainres.2017.12.004. Epub 2017 Dec 8.

PMID:
29229502
25.

Combined deficiency of factors V and VIII by chance coinheritance of parahaemophilia and haemophilia A, but not by mutations of either LMAN1 or MCFD2, in a Japanese family.

Suzuki S, Nakamura Y, Suzuki N, Yamazaki T, Takagi Y, Tamura S, Takagi A, Kanematsu T, Matsushita T, Kojima T.

Haemophilia. 2018 Jan;24(1):e13-e16. doi: 10.1111/hae.13360. Epub 2017 Oct 30. No abstract available.

PMID:
29082580
26.

Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signalling.

Asano S, Taniguchi Y, Yamawaki Y, Gao J, Harada K, Takeuchi H, Hirata M, Kanematsu T.

Sci Rep. 2017 Jul 14;7(1):5408. doi: 10.1038/s41598-017-05908-7.

27.

Phospholipase C-related catalytically inactive protein can regulate obesity, a state of peripheral inflammation.

Yamawaki Y, Oue K, Shirawachi S, Asano S, Harada K, Kanematsu T.

Jpn Dent Sci Rev. 2017 Feb;53(1):18-24. doi: 10.1016/j.jdsr.2016.06.001. Epub 2016 Jun 27. Review.

28.

Propofol Anesthesia Is Reduced in Phospholipase C-Related Inactive Protein Type-1 Knockout Mice.

Nikaido Y, Furukawa T, Shimoyama S, Yamada J, Migita K, Koga K, Kushikata T, Hirota K, Kanematsu T, Hirata M, Ueno S.

J Pharmacol Exp Ther. 2017 Jun;361(3):367-374. doi: 10.1124/jpet.116.239145. Epub 2017 Apr 12.

PMID:
28404686
29.

General anesthetic actions on GABAA receptors in vivo are reduced in phospholipase C-related catalytically inactive protein knockout mice.

Hayashiuchi M, Kitayama T, Morita K, Yamawaki Y, Oue K, Yoshinaka T, Asano S, Harada K, Kang Y, Hirata M, Irifune M, Okada M, Kanematsu T.

J Anesth. 2017 Aug;31(4):531-538. doi: 10.1007/s00540-017-2350-2. Epub 2017 Apr 7.

PMID:
28389811
30.

Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-induced obesity and insulin resistance.

Sano T, Nagayasu S, Suzuki S, Iwashita M, Yamashita A, Shinjo T, Sanui T, Kushiyama A, Kanematsu T, Asano T, Nishimura F.

Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):249-259. doi: 10.1016/j.numecd.2016.11.008. Epub 2016 Nov 23.

PMID:
28062181
31.

Retrospective analysis of in vivo recovery and clearance during continuous infusion of recombinant factor VIII products: a single-institution study.

Suzuki N, Hirakawa A, Kishimoto M, Kanematsu T, Ogawa M, Kiyoi H, Matsushita T.

Haemophilia. 2017 Mar;23(2):215-221. doi: 10.1111/hae.13082. Epub 2016 Oct 5.

PMID:
27704637
32.

Phospholipase C-related Catalytically Inactive Protein Is a New Modulator of Thermogenesis Promoted by β-Adrenergic Receptors in Brown Adipocytes.

Oue K, Zhang J, Harada-Hada K, Asano S, Yamawaki Y, Hayashiuchi M, Furusho H, Takata T, Irifune M, Hirata M, Kanematsu T.

J Biol Chem. 2016 Feb 19;291(8):4185-96. doi: 10.1074/jbc.M115.705723. Epub 2015 Dec 25.

33.

The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese.

Kishimoto M, Suzuki N, Murata M, Ogawa M, Kanematsu T, Takagi A, Kiyoi H, Kojima T, Matsushita T.

Ann Hematol. 2016 Feb;95(3):541-2. No abstract available.

PMID:
26482463
34.

[A Successful Case of Negative Pressure Pulmonary Edema Treated with Short-term Continuous Positive Airway Pressure Therapy].

Nakata T, Makino H, Kato T, Senba M, Kohno M, Kajiwara K, Itou K, Hamaguchi N, Kanematsu T, Yokoyama H.

Nihon Naika Gakkai Zasshi. 2015 Oct;104(10):2206-11. Japanese. No abstract available.

PMID:
30161318
35.

A case of MYH9 disorders caused by a novel mutation (p.K74E).

Kanematsu T, Suzuki N, Yoshida T, Kishimoto M, Aoki T, Ogawa M, Kagami Y, Kiyoi H, Matsushita T, Kunishima S.

Ann Hematol. 2016 Jan;95(1):161-163. doi: 10.1007/s00277-015-2506-9. Epub 2015 Sep 17. No abstract available.

PMID:
26382273
36.

[New molecular basis in the regulation of lipolysis via dephosphorylation].

Oue K, Harada-Hada K, Kanematsu T.

Nihon Yakurigaku Zasshi. 2015 Aug;146(2):93-7. doi: 10.1254/fpj.146.93. Review. Japanese. No abstract available.

PMID:
26256747
37.

Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).

Katsuno H, Maeda K, Ohya M, Yoshioka K, Tsunoda A, Koda K, Matsuoka H, Ohge H, Morita S, Saji S, Kanematsu T, Kitajima M.

J Gastroenterol. 2016 Mar;51(3):222-9. doi: 10.1007/s00535-015-1100-1. Epub 2015 Jul 11.

PMID:
26162646
38.

Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.

Yoshikawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y, Sakamoto J, Shiraishi N, Koeda K, Mochiki E, Saikawa Y, Yamaguchi K, Watanabe M, Morita S, Kitano S, Saji S, Kanematsu T, Kitajima M.

J Am Coll Surg. 2015 Aug;221(2):571-8. doi: 10.1016/j.jamcollsurg.2015.03.004. Epub 2015 Mar 14.

PMID:
26141466
39.

Lung cancer surgery in patients aged 80 years or older: an analysis of risk factors, morbidity, and mortality.

Miura N, Kohno M, Ito K, Senba M, Kajiwara K, Hamaguchi N, Makino H, Kanematsu T, Okamoto T, Yokoyama H.

Gen Thorac Cardiovasc Surg. 2015 Jul;63(7):401-5. doi: 10.1007/s11748-015-0546-7. Epub 2015 Apr 14.

PMID:
25868520
40.

Enhanced vaccination effect against influenza by prebiotics in elderly patients receiving enteral nutrition.

Akatsu H, Nagafuchi S, Kurihara R, Okuda K, Kanesaka T, Ogawa N, Kanematsu T, Takasugi S, Yamaji T, Takami M, Yamamoto T, Ohara H, Maruyama M.

Geriatr Gerontol Int. 2016 Feb;16(2):205-13. doi: 10.1111/ggi.12454. Epub 2015 Jan 22.

PMID:
25613751
41.

Enhanced lateral inhibition in the barrel cortex by deletion of phospholipase C-related catalytically inactive protein-1/2 in mice.

Toyoda H, Saito M, Sato H, Kawano T, Kawakami S, Yatani H, Kanematsu T, Hirata M, Kang Y.

Pflugers Arch. 2015 Jul;467(7):1445-1456. doi: 10.1007/s00424-014-1592-1. Epub 2014 Aug 28.

PMID:
25163765
42.

Relief of cancer pain by glycine transporter inhibitors.

Motoyama N, Morita K, Shiraishi S, Kitayama T, Kanematsu T, Uezono Y, Dohi T.

Anesth Analg. 2014 Oct;119(4):988-95. doi: 10.1213/ANE.0000000000000388.

PMID:
25076101
43.

Phospholipase C-related catalytically inactive protein (PRIP) regulates lipolysis in adipose tissue by modulating the phosphorylation of hormone-sensitive lipase.

Okumura T, Harada K, Oue K, Zhang J, Asano S, Hayashiuchi M, Mizokami A, Tanaka H, Irifune M, Kamata N, Hirata M, Kanematsu T.

PLoS One. 2014 Jun 19;9(6):e100559. doi: 10.1371/journal.pone.0100559. eCollection 2014.

44.

Selective blockade of N-methyl-D-aspartate channels in combination with dopamine receptor antagonism induces loss of the righting reflex in mice, but not immobility.

Kikuchi N, Irifune M, Shimizu Y, Yoshida K, Morita K, Kanematsu T, Morioka N, Nakata Y, Sakai N.

Psychopharmacology (Berl). 2015 Jan;232(1):39-46. doi: 10.1007/s00213-014-3634-y. Epub 2014 May 31.

PMID:
24879496
45.

Phospholipase C-related catalytically inactive protein participates in the autophagic elimination of Staphylococcus aureus infecting mouse embryonic fibroblasts.

Harada-Hada K, Harada K, Kato F, Hisatsune J, Tanida I, Ogawa M, Asano S, Sugai M, Hirata M, Kanematsu T.

PLoS One. 2014 May 27;9(5):e98285. doi: 10.1371/journal.pone.0098285. eCollection 2014.

46.

Phospholipase C-related catalytically inactive protein (PRIP) controls KIF5B-mediated insulin secretion.

Asano S, Nemoto T, Kitayama T, Harada K, Zhang J, Harada K, Tanida I, Hirata M, Kanematsu T.

Biol Open. 2014 May 8;3(6):463-74. doi: 10.1242/bio.20147591.

47.

Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer.

Kimura M, Usami E, Kanematsu T, Iwai M, Yoshimura T, Mori H, Sugiyama T, Teramachi H.

Mol Clin Oncol. 2014 May;2(3):466-472. Epub 2014 Feb 14.

48.

Enhanced desensitization followed by unusual resensitization in GABAA receptors in phospholipase C-related catalytically inactive protein-1/2 double-knockout mice.

Toyoda H, Saito M, Sato H, Tanaka T, Ogawa T, Yatani H, Kawano T, Kanematsu T, Hirata M, Kang Y.

Pflugers Arch. 2015 Feb;467(2):267-84. doi: 10.1007/s00424-014-1511-5. Epub 2014 Apr 16.

PMID:
24737248
49.

Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B.

Usami E, Kimura M, Kanematsu T, Yoshida S, Mori T, Nakashima K, Matsuoka T, Yoshimura T, Mori H, Sugiyama T, Teramachi H.

Exp Ther Med. 2014 Apr;7(4):941-946. Epub 2014 Feb 11.

50.

Palliation of bone cancer pain by antagonists of platelet-activating factor receptors.

Morita K, Shiraishi S, Motoyama N, Kitayama T, Kanematsu T, Uezono Y, Dohi T.

PLoS One. 2014 Mar 17;9(3):e91746. doi: 10.1371/journal.pone.0091746. eCollection 2014.

Supplemental Content

Loading ...
Support Center